CytoDyn (CYDY) Cash & Equivalents (2010 - 2026)
CytoDyn's Cash & Equivalents came in at $16.36 million for fiscal Q1 2027 (quarter ended Aug 31, 2026), up 75.3% from $9.33 million a year earlier and up 38.0% from the prior quarter.
Powered by 
Analysis
CytoDyn (CYDY) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2026 (ended May 31, 2026), CytoDyn's Cash & Equivalents was $11.85 million, down 0.4% from FY2025.
- Cash & Equivalents carries a five-year compound annual growth rate of -19.0% (FY2021 to FY2026).
- Going back by fiscal year, Cash & Equivalents was $11.9 million in FY2025 (+282.7%), $3.11 million in FY2024 (+22.4%), $2.54 million in FY2023 (-39.9%) and $4.23 million in FY2022 (-87.5%).
- The fiscal Q1 2027 figure represents the highest quarterly Cash & Equivalents since fiscal Q3 2025.
- Year-over-year, Cash & Equivalents increased in two of the last six quarters, with growth averaging 35.6%.
- The fastest year-over-year change in Cash & Equivalents over five years came in fiscal Q4 2025 (growth of 282.7%), and the weakest in fiscal Q2 2024 (a decline of 93.9%).
- Business Quant data shows CYDY's Cash & Equivalents at $11.85 million (Q4 2026), $15.66 million (Q3 2026) and $4.98 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 976.00 Mn |
| 10 | CytoDyn | 367.38 Mn | 318.53 Mn | - | 16.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 16.36 Mn |
| May 31, 2026 | 11.85 Mn |
| Feb 28, 2026 | 15.66 Mn |
| Nov 30, 2025 | 4.98 Mn |
| Aug 31, 2025 | 9.33 Mn |
| May 31, 2025 | 11.90 Mn |
| Feb 28, 2025 | 16.40 Mn |
| Nov 30, 2024 | 21.34 Mn |
| Aug 31, 2024 | 24.92 Mn |
| May 31, 2024 | 3.11 Mn |
| Feb 29, 2024 | 1.40 Mn |
| Nov 30, 2023 | 147,000.00 |
| Aug 31, 2023 | 2.03 Mn |
| May 31, 2023 | 2.54 Mn |
| Feb 28, 2023 | 5.11 Mn |
| Nov 30, 2022 | 2.40 Mn |
| Aug 31, 2022 | 4.68 Mn |
| May 31, 2022 | 4.23 Mn |
| Feb 28, 2022 | 1.36 Mn |
| Nov 30, 2021 | 8.88 Mn |
API Access
CytoDyn Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CYDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CYDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CYDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();